(Q37905857)

25 August 2017

1 reference

title

Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist (English)

1 reference

25 August 2017

1 reference

Richard L Jackson

1

1 reference

25 August 2017

Jeffrey S Greiwe

series ordinal

2

1 reference

25 August 2017

Richard J Schwen

series ordinal

3

1 reference

25 August 2017

publication date

1 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

69

1 reference

25 August 2017

issue

8

1 reference

25 August 2017

page(s)

432-448

1 reference

Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

The constitution of equol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soya--a dietary source of the non-steroidal oestrogen equol in man and animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Eggerthella strain Julong 732.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Urinary equol excretion with a soy challenge: influence of habitual diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Estimated Asian adult soy protein and isoflavone intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Emerging research on equol and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

WHI and WHIMS follow-up and human studies of soy isoflavones on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soy, phytoestrogens and metabolism: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Menopausal hot flashes: a review of physiology and biosociocultural perspective on methods of assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Physiology of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Phytoestrogens in clinical practice: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Interaction of phytoestrogens with estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Estrogenic control of thermoregulation in ERalphaKO and ERbetaKO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soy phytoestrogens: impact on postmenopausal bone loss and mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Localization of estrogen receptor beta protein expression in adult human bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Androgen receptor expression in the rat prostate is down-regulated by dietary phytoestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Antioxidant activity of isoflavones and their major metabolites using different in vitro assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Effects of equol on oxidized low-density lipoprotein-induced apoptosis in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isolation and identification of equol-producing bacterial strains from cultures of pig faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Enhanced biosynthesis of dihydrodaidzein and dihydrogenistein by a newly isolated bovine rumen anaerobic bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isolation and characterization of a novel equol-producing bacterium from human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isolation of a human intestinal bacterium capable of daidzein and genistein conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

EXCRETION OF THE LIGNANS ENTEROLACTONE AND ENTERODIOL AND OF EQUOL IN OMNIVOROUS AND VEGETARIAN POSTMENOPAUSAL WOMEN AND IN WOMEN WITH BREAST CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2011.00400.X

10.1111/J.1753-4887.2011.00400.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference